Related Experiment Video
Updated: Aug 6, 2026
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
BCG at Home: A First-in-kind Trial of Home-based Intravesical Bacillus Calmette-Guérin Delivery for High-risk
Daniel J Lee1, Cheyenne Williams1, Scott Soefje2
1Division of Urology, University of Pennsylvania, Philadelphia, PA, USA.
European Urology Focus
|July 22, 2026
Abstract:
We present, for the first time, a prospective trial of Bacillus Calmette-Guérin (BCG) at home. We implemented a training program for nurses and used a special device that allows sterile delivery of BCG to the home setting. Using a texting chatbot allowed us to capture patient-reported outcomes and symptoms in real time. In our analysis of the first eight patients, we found that treating the BCG at home was safe and effective.
